Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Theranostic PET for Target Validation and Tumor Detection

NCT07664410 is registered in ClinicalTrials.gov with University Hospital, Essen as lead sponsor.

NCT NCT07664410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07664410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Theranostic PET for Target Validation and Tumor Detection
Lead sponsor
University Hospital, Essen
Phase
Observational
Overall status
Recruiting
Start date
September 23, 2025
Completion date
September 23, 2035
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid malignancies